Predicted neoantigen load in non-hypermutated endometrial cancers: Correlation with outcome and tumor-specific genomic alterations

Abstract excerpt

Elevated neoantigen load has been previously correlated with improved outcome and response to immune checkpoint blockade in various tumor types. In endometrial cancer, previous studies of neoantigen load prediction have shown that the hypermutated MSI and POLE-mutated tumors harbor significantly higher predicted neoantigen load compared to the hypomutated CN-low/endometrioid and CN-high/serous-like tumors. Here,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Endometrial and Cervical Cancer Treatments
• Share to Lymphoma Diagnosis and Treatment
• Share to Ovarian cancer diagnosis and treatment